| Phenotype: | whole organism increased sensitivity toward whole organism PABA/NO, abnormal |
|---|---|
| Note: | This statement combines anatomy and/or ontology terms with phenotype quality terms to create a complete phenotype (EQ) statement. For detailed information on individual terms, click the hyperlinked term name. |
| Name: | whole organism |
|---|---|
| Synonyms: | multi-cellular organism |
| Definition: | Anatomical structure that is an individual member of Danio rerio. |
| Ontology: | Anatomy Ontology [ZFA:0001094] |
| Name: | increased sensitivity toward |
|---|---|
| Synonyms: | high sensitivity toward, increased sensitivity |
| Definition: | A sensitivity toward an external stimulus which is higher than normal/average. |
| Ontology: | Phenotypic Quality Ontology [PATO:0001549] |
| Name: | PABA/NO |
|---|---|
| Synonyms: | 5-[(3,3-dimethyl-2-oxido-1-triazen-1-yl)oxy]-2,4-dinitrophenyl 4-(methylamino)benzoate, 5-[(3,3-dimethyl-2-oxido-2lambda(5)-triaz-1-en-1-yl)oxy]-2,4-dinitrophenyl 4-(methylamino)benzoate, O(2)-(2,4-dinitro-5-(4-(N-methylamino)benzoyloxy)phenyl) 1-(N,N-dimethylamino)diazen-1-ium-1,2-diolate, PABA/NO |
| Definition: | A C-nitro compound that is benzene substituted by [4-(methylamino)benzoyl]oxy, nitro, nitro, and (3,3-dimethyl-2-oxido-2lambda(5)-triaz-1-en-1-yl)oxy groups at positions 1, 2, 4, and 5, respectively. It is an anti-cancer compound that is designed to release NO upon activation by glutathione. |
| Ontology: | ChEBI [CHEBI:195533] ( EBI ) |